Recall Record

Indianapolis, IN, United States

Roche Diagnostics Corporation recalls

21 recalls recorded since 2018, most recently on 3 June 2019. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls21
Ongoing (FDA)0
Terminated or completed21
Class I (FDA)1

Terminated Class II Medical devices

Recall started
3 June 2019
Terminated
28 August 2020
Reason
Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.
Distribution
The products were distributed to the following US states: AL, IN, and KY.
Initiated
Voluntary: Firm initiated
Recall number
Z-1979-2019

Terminated Class III Medical devices

Recall started
4 April 2019
Terminated
12 May 2020
Reason
There is a potential for the tray input flap on the post analytical units to become loose, potentially detaching from the instrument.
Distribution
US Nationwide Distribution in the states of AL, CA, FL, IA, IL, KY, MD, OR & PA
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1927-2019, Z-1928-2019

Terminated Class II Medical devices

Recall started
18 March 2019
Terminated
28 August 2020
Reason
The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values.
Distribution
US Nationwide distribution in the states of: GA, IL, KY, MI, and TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-1194-2019

Terminated Class II Medical devices

Recall started
15 March 2019
Terminated
23 April 2020
Reason
The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.
Distribution
Distributed to accounts in AL AZ CA CT FL HI IA IL IN KY LA MA MD ME MI MN MO NC NH NJ NY OH OR PA PR SC TN TX VA WA WI
Initiated
Voluntary: Firm initiated
Recall number
Z-1249-2019

Terminated Class II Medical devices

Recall started
4 February 2019
Terminated
16 September 2020
Reason
Using the following versions of cobas infinity software (2.0 thorough 2.5), there is a potential where the results from the first sample subsequent to the bottle change, (when using the Standby bottle function), does not display a quality control (QC) alarm when one should be present. If the QC is out of range on the stand-by bottle and it is not removed from the system, there is a potential that when the status of the Standby bottle changes from the Standby bottle to the Current bottle status, QC alarms will not be displayed next to the sample result.
Distribution
US Distribution to states of: AL, AZ, CA, GA, IA, MO, NJ, NY, SC, TN and TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-1368-2019

Terminated Class II Medical devices

Recall started
17 December 2018
Terminated
2 November 2020
Reason
New endogenous interference claims have been established for the following assays used on the cobas c 311 analyzer and the cobas c 501, 502, 701, 702, and Modular Analytics P/D modules which may have potential medical risk. ***Update: Cobas c111 and COBAS INTEGRA 400 plus analyzers are also impacted for BILT3 and LACT2 assays***
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1146-2019, Z-1145-2019, Z-1147-2019

Terminated Class II Medical devices

Recall started
17 December 2018
Terminated
10 April 2020
Reason
Potential for erroneous result messages for the Anti-HAV IgM assay when run on the cobas e 602 module. Discrepant result reporting may result.
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0784-2019

Terminated Class II Medical devices

Recall started
14 December 2018
Terminated
4 September 2020
Reason
COBAS INTEGRA¿ 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-over
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1124-2019, Z-1125-2019

Terminated Class II Medical devices

Recall started
24 September 2018
Terminated
9 February 2022
Reason
Limits of Detection (LoD) for protein, nitrite, leukocytes, and erythrocytes on the Urisys 1100 urine analyzer with Chemstrip 5 OB, Chemstrip 7, Chemstrip 10 MD, and Chemstrip 10 UA test strips were higher than what is listed in the test strip method sheets may lead to false negative results for the affected parameters
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0301-2019

Terminated Class I Medical devices

Recall started
13 September 2018
Terminated
16 October 2020
Reason
Abnormally high INR test results with the affected CoaguChek test strips
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0360-2019

Terminated Class II Medical devices

Recall started
16 July 2018
Terminated
16 May 2019
Reason
Sample material may potentially come in contact with the pipetting nozzle during operation of cobas p 612 pre-analytical system (63x) (LCP1) with non-filter tips. The possible presence of biological material on the nozzle may cause contamination resulting in potential false positive results, depending on the sensitivity of the analytical technology.
Distribution
US Distribution to states of: CA, NY,TX, WA, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-2944-2018

Terminated Class II Medical devices

Recall started
27 April 2018
Terminated
11 May 2020
Reason
The device may give a falsely elevated result that is non-reproducible. If vitamin D level is monitored by laboratory tests and adapted based on the result, a dosage reduction of vitamin D supplementation cannot be excluded, and as a consequence, vitamin D deficiency may develop over time.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2390-2018, Z-2389-2018

Terminated Class II Medical devices

Recall started
3 April 2018
Terminated
21 November 2019
Reason
The syringe plunger on the device may be mounted in a tilted position, which applies mechanical stress to the plunger. In the worst case scenario, the plunger may crack leading to impaired syringe function.
Distribution
US Distribution to the states of : CA, CT, IA, IN, KY, ME, MI, NC, NY, OH, SC, TX, and VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2136-2018

Terminated Class II Medical devices

Recall started
22 February 2018
Terminated
15 November 2019
Reason
The software responsible for starting scheduled AutoQC measurements (scheduler) will not activate.
Distribution
USA ( nationwide)
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1613-2018, Z-1610-2018, Z-1612-2018, Z-1611-2018

Terminated Class II Medical devices

Recall started
2 January 2018
Terminated
25 April 2019
Reason
The previous version of method sheets for the Acetaminophen assay on the COBAS INTEGRA 400 plus/800/800 CTS analyzers and the MODULAR ANALYTICS P module are missing the following statement in the Limitations-interference section: "In very rare cases, gammopathy, in particular type IgM (Waldenstr¿m s macroglobulinemia), may cause unreliable results."
Distribution
Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-1519-2018

Terminated Class II Medical devices

Recall started
22 December 2017
Terminated
5 April 2019
Reason
Product exhibits a decreased recovery of patient samples on the cobas e 801 module compared to the MODULAR ANALYTICS E 170, cobas e 411, 601, and 602 analyzers.
Distribution
US Distribution in states of: CA, FL and IN.
Initiated
Voluntary: Firm initiated
Recall number
Z-1311-2018

Terminated Class II Medical devices

Recall started
18 December 2017
Terminated
9 April 2019
Reason
Complaints have been received concerning questionable results on analyzers due to customers utilizing 13 sample tubes without tube adapters.
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1268-2018, Z-1270-2018, Z-1269-2018

Terminated Class II Medical devices

Recall started
28 July 2017
Terminated
10 June 2020
Reason
A software failure may incorrectly set the system settings to "default" settings, creating a risk of incorrect results.
Distribution
Distributed in 36 states: AL, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, TN, TX, UT, VA, WA, WI and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-0675-2018

Terminated Class II Medical devices

Recall started
18 July 2017
Terminated
13 July 2018
Reason
A warning is being added to the cobas¿ 6000 MODULAR Series System - c501 and the cobas¿ 8000 MODULAR Analyzer Series - c502 Operator Manuals to prevent operator injury during maintenance.
Distribution
Distributed in all 50 states: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MN, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, the District of Columbia, and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0909-2018, Z-0910-2018

Terminated Class II Medical devices

Recall started
5 July 2017
Terminated
30 April 2019
Reason
A software malfunction can occur on the cobas e 411 and Elecsys 2010 analyzers in the Sample& Control data file which may lead to a potential data mismatch.
Distribution
Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0498-2018, Z-0499-2018

Terminated Class II Medical devices

Recall started
29 June 2017
Terminated
24 January 2020
Reason
Roche has confirmed that a possible sample mismatch issue may occur on the MODULAR ANALYTICS E 170 module, cobas e 601 analyzer, or cobas e 602 analyzer due to a software limitation.
Distribution
USA (nationwide) Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-0378-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.